Preclinical Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Preclinical Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-22Clinical Trial Update: DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau [Phase 1]
Nuravax, Inc. is conducting a Phase 1 vaccine study (DUVAX) for Alzheimer's disease that targets amyloid-beta and tau, and the trial is curr…
-
CLINICAL_TRIALS other · 2025-09-08Clinical Trial Update: AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980) [Phase 1]
Phase 1 clinical trial update for AV-1980R tau vaccine in preclinical Alzheimer's disease; trial status NOT_YET_RECRUITING.
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Financial Incentives and Recruitment to the APT Webstudy [NA]
This entry reports a USC-sponsored clinical trial update on using financial incentives to recruit participants to the APT Webstudy for Alzhe…
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Alzheimer's Plasma Extension
USC-sponsored clinical trial evaluating plasma extension for Alzheimer's disease is active but not recruiting, focusing on preclinical stage…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: β-AARC: Cohort Study for the Identification of Blood-based Biomarkers in a Population With Subjective Cognitive Decline
A cohort study sponsored by Barcelonabeta Brain Research Center and Pasqual Maragall Foundation to identify blood-based biomarkers in indivi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2024-06-14Clinical Trial Update: Amyloid Prediction in Early Stage Alzheimer's Disease Through Speech Phenotyping - FUTURE Extension
Clinical trial update on amyloid prediction in early-stage Alzheimer's disease through speech phenotyping (FUTURE Extension) indicates the s…